Federation des caisses Desjardins du Quebec’s Niagen Bioscience NAGE Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.41K	Hold	1,000	–	–	﹤0.01%	2530
2025 Q4	$6.36K	Hold	1,000	–	–	﹤0.01%	2384
2025 Q3	$9.33K	Hold	1,000	–	–	﹤0.01%	2287
2025 Q2	$14.4K	Hold	1,000	–	–	﹤0.01%	1902
2025 Q1	$6.9K	Hold	1,000	–	–	﹤0.01%	2078
2024 Q4	$5.3K	Sell	1,000 -1,000	-50%	-$5.47K	﹤0.01%	2066
2024 Q3	$7.3K	Hold	2,000	–	–	﹤0.01%	1987
2024 Q2	$5.46K	Hold	2,000	–	–	﹤0.01%	1943
2024 Q1	$6.96K	Buy	+2,000	New	+$3.7K	﹤0.01%	1892
2023 Q4	–	Sell	-12,025	Closed	-$17.6K	–	2471
2023 Q3	$17.6K	Hold	12,025	–	–	﹤0.01%	1613
2023 Q2	$18.9K	Hold	12,025	–	–	﹤0.01%	1594
2023 Q1	$18.4K	Buy	12,025 +10,625	+759%	+$18.9K	﹤0.01%	1591
2022 Q4	$2.35K	Sell	1,400 -3,035	-68%	-$4.81K	﹤0.01%	2184
2022 Q3	$5.46K	Hold	4,435	–	–	﹤0.01%	2057
2022 Q2	$7.41K	Hold	4,435	–	–	﹤0.01%	2028
2022 Q1	$10.9K	Hold	4,435	–	–	﹤0.01%	2001
2021 Q4	$16.6K	Hold	4,435	–	–	﹤0.01%	1893
2021 Q3	$27.8K	Hold	4,435	–	–	﹤0.01%	1755
2021 Q2	$43.7K	Hold	4,435	–	–	﹤0.01%	1647
2021 Q1	$41.4K	Hold	4,435	–	–	﹤0.01%	1598
2020 Q4	$21.3K	Buy	+4,435	New	+$21.6K	﹤0.01%	1728

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's NAGE Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Niagen Bioscience (NAGE) position steady in Q1 2026 at 1,000 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

Federation des caisses Desjardins du Quebec first reported a position in NAGE in Q4 2020 and has held it in 21 quarters since. The position peaked at $43.7K in Q2 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Federation des caisses Desjardins du Quebec held 1,000 shares of Niagen Bioscience worth $4.41K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Niagen Bioscience share count unchanged in Q1 2026.
Niagen Bioscience made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2530 holding.
Federation des caisses Desjardins du Quebec first reported a position in Niagen Bioscience in Q4 2020 and has held it in 21 quarters since.
Federation des caisses Desjardins du Quebec's Niagen Bioscience position peaked at $43.7K in Q2 2021.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.